UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia

The Lancet (British edition), 1997-10, Vol.350 (9086), p.1222-1222

1997

Link zum Volltext

Verfügbarkeit prüfen

Rebuttal to circulating IL-6 levels in chronic obstructive pulmonary disease

Thrombosis and haemostasis, 2001-02, Vol.85 (2), p.373

2001

Link zum Volltext

Verfügbarkeit prüfen

Increased thromboxane metabolites excretion in liver cirrhosis

Thrombosis and haemostasis, 1998-04, Vol.79 (4), p.747

1998

Link zum Volltext

Verfügbarkeit prüfen

Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis

Gastroenterology (New York, N.Y. 1943), 1995-08, Vol.109 (2), p.531-539

1995

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration

Atherosclerosis, 1990-06, Vol.82 (3), p.247-252

1990

Link zum Volltext

Verfügbarkeit prüfen

Enhanced lipid peroxidation in hepatic cirrhosis

Journal of investigative medicine, 1998-02, Vol.46 (2), p.51

1998

Link zum Volltext

Verfügbarkeit prüfen

Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease

American journal of respiratory and critical care medicine, 1997-12, Vol.156 (6), p.1794-1799

1997

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease

Atherosclerosis, 1999-12, Vol.147 (2), p.249-252

1999

Link zum Volltext

Verfügbarkeit prüfen

Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease

Journal of investigative medicine, 2000-01, Vol.48 (1), p.21

2000

Link zum Volltext

Verfügbarkeit prüfen

Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis

Hepatology (Baltimore, Md.), 1992-04, Vol.15 (4), p.672-676

1992

Link zum Volltext

Verfügbarkeit prüfen

Reply to: Lipoprotein (a) and chronic obstructive pulmonary disease

Atherosclerosis, 2001-04, Vol.155 (2), p.525-526

2001

Link zum Volltext

Verfügbarkeit prüfen

Hyperfibrinolysis Resulting from Clotting Activation in Patients with Different Degrees of Cirrhosis

Hepatology (Baltimore, Md.), 1993-01, Vol.17 (1), p.78-83

1993

Link zum Volltext

Verfügbarkeit prüfen

Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities

Journal of hepatology, 1994, Vol.20 (4), p.531-536

1994

Link zum Volltext

Verfügbarkeit prüfen

Chronic Obstructive Pulmonary Disease Is Associated with an Increase in Urinary Levels of Isoprostane F 2 α -III, an Index of Oxidant Stress

American journal of respiratory and critical care medicine, 1998-12, Vol.158 (6), p.1709-1714

1998

Link zum Volltext

Verfügbarkeit prüfen

Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis

Journal of hepatology, 1996-05, Vol.24 (5), p.574-580

1996

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients

Hepatology (Baltimore, Md.), 1995, Vol.22 (1), p.96-100

1995

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein (a) serum levels in patients with hepatocarcinoma

Clinica chimica acta, 1997-06, Vol.262 (1), p.53-60

1997

Link zum Volltext

Verfügbarkeit prüfen

Signal-averaged electrocardiography and echocardiography in the evaluation of myocardial involvement in progressive systemic sclerosis

International journal of cardiology, 1996-02, Vol.53 (2), p.171-177

1996

Link zum Volltext

Verfügbarkeit prüfen

Relationship between lipoprotein(a) levels in serum and some indices of protein synthesis in liver cirrhosis

Clinica chimica acta, 1994-01, Vol.224 (2), p.125-129

1994

Link zum Volltext

Verfügbarkeit prüfen

Soluble P-Selectin and Proinflammatory Cytokines in Patients with Polygenic Type IIa Hypercholesterolemia

Haemostasis, 1999-01, Vol.29 (5), p.277-285

1999

Link zum Volltext

Verfügbarkeit prüfen

Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis

Hepatology (Baltimore, Md.), 1993, Vol.17 (1), p.78-83

1993

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of clotting and fibrinolytic systems in a follow‐up of 165 liver cirrhotic patients

Hepatology (Baltimore, Md.), 1995-07, Vol.22 (1), p.96-100

1995

Link zum Volltext

Verfügbarkeit prüfen

POTENTIAL USEFULNESS OF ANTIPLATELET AGENTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Thrombosis research, 1996-11, Vol.84 (4), p.279-284

1996

Link zum Volltext

Verfügbarkeit prüfen

Clotting abnormalities in chronic liver disease

Digestive diseases (Basel), 1992, Vol.10 (3), p.162

1992

Link zum Volltext

Verfügbarkeit prüfen

Improvement of blood gas levels after calcium-heparin treatment in patients with chronic obstructive pulmonary disease

Thrombosis research, 1992-12, Vol.68 (4), p.435-440

1992

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Humans
(24)
Biological And Medical Sciences
(21)
Medical Sciences
(21)
Male
(19)
Female
(18)
Middle Aged
(17)
Aged
(16)
Adult
(11)
Gastroenterology. Liver. Pancreas. Abdomen
(10)
Cardiovascular System & Cardiology
(9)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(9)
Other Diseases. Semiology
(9)
Peripheral Vascular Disease
(8)
Gastroenterology & Hepatology
(7)
Risk Factors
(7)
Liver Cirrhosis - Blood
(6)
Pharmacology. Drug Treatments
(6)
Aged, 80 And Over
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Simvastatin reduces monocyte-tissue-factor expression type IIa hypercholesterolaemia

Rebuttal to circulating IL-6 levels in chronic obstructive pulmonary disease

Increased thromboxane metabolites excretion in liver cirrhosis

Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis

Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration

Enhanced lipid peroxidation in hepatic cirrhosis

Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease

Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease

Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease

Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosis

Reply to: Lipoprotein (a) and chronic obstructive pulmonary disease

Hyperfibrinolysis Resulting from Clotting Activation in Patients with Different Degrees of Cirrhosis

Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities

Chronic Obstructive Pulmonary Disease Is Associated with an Increase in Urinary Levels of Isoprostane F 2 α -III, an Index of Oxidant Stress

Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis

Prognostic value of clotting and fibrinolytic systems in a follow-up of 165 liver cirrhotic patients

Lipoprotein (a) serum levels in patients with hepatocarcinoma

Signal-averaged electrocardiography and echocardiography in the evaluation of myocardial involvement in progressive systemic sclerosis

Relationship between lipoprotein(a) levels in serum and some indices of protein synthesis in liver cirrhosis

Soluble P-Selectin and Proinflammatory Cytokines in Patients with Polygenic Type IIa Hypercholesterolemia

Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis

Prognostic value of clotting and fibrinolytic systems in a follow‐up of 165 liver cirrhotic patients

POTENTIAL USEFULNESS OF ANTIPLATELET AGENTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Clotting abnormalities in chronic liver disease

Improvement of blood gas levels after calcium-heparin treatment in patients with chronic obstructive pulmonary disease

Suchergebnisse filtern